ArticleCancer discovery2018
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound
Satoshi Yoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
195 papers cite itlatest 60 shown
this paperpooled ittrialcites it